Drug details:
Molecular formula: C₁₀H₁₈N₄O₄

Standard name: (5R)-6-[(4R)-2-amino-1-carbamoyl-4,5-dihydroimidazol-4-yl]-5-hydroxyhexanoic acid

Curated SMILES: C1[C@H](N=C(N1C(=O)N)N)C[C@@H](CCCC(=O)O)O

Evidence for compound's anti-virulence activity:

Escherichia
Related VF: TTSS (Type III secretion system)
Target: Not determined
Drug effect: Markedly inhibit EPEC-induced hemolysis.
Max phase: Preclinical (in vitro)
Publication:
Iwatsuki M, et al., 2008. Guadinomines, Type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. I: taxonomy, fermentation, isolation and biological properties. J Antibiot (Tokyo) 61(4):222-9.